Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
published in: Breast Cancer Research and Treatment
date of publication: 2009-02-24
language: English
main subject: tamoxifen
Cites articles 4
Date
Title
Article - wd:Q39880360